To scroll text in this page

Global Navigation
Global Navigation end

About Astellas

Start of the main text

2018 News Releases

About RSS

Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients (pdf 359KB)

January 22, 2018

Printer-friendly version


Main Text end
Local Navigation
Local Navigation end
Related Links